Evidence map›Paper›PMID 34804573›Full record

ArticleRoyal Society open science2021

Aneurysm risk metrics and hemodynamics are associated with greater vessel wall enhancement in intracranial aneurysms.

Sricharan S Veeturi, Hamidreza Rajabzadeh-Oghaz, Nándor K Pintér, Muhammad Waqas, David M Hasan, Kenneth V Snyder, Adnan H Siddiqui, Vincent M Tutino

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sricharan S VeeturiCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY, USA.ORCID 0000-0002-8114-3817
Hamidreza Rajabzadeh-OghazCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY, USA.
Nándor K PintérDENT Neurologic Institute, Buffalo, NY, USA.ORCID 0000-0002-7714-143X
Muhammad WaqasCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY, USA.
David M HasanDepartment of Neurosurgery, University of Iowa Health Care, Iowa City, IA, USA.
Kenneth V SnyderCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY, USA.
Adnan H SiddiquiCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY, USA.
Vincent M TutinoCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY, USA.
University at Buffalo, State University of New York · USDent Neurologic Institute · USUniversity of Iowa Health Care · US

Funding

Molecular Biomarkers of Dangerous Intracranial AneurysmsR43NS115314 · NINDS · NEUROVASCULAR DIAGNOSTICS, INC. · PI TUTINO, VINCENT MATTHEW · 2019 to 2019
$225k
NINDS NIH HHS R43 NS115314
6 · The paper itself

Abstract

Vessel wall enhancement (VWE) in contrast-enhanced magnetic resonance imaging (MRI) is a potential biomarker for intracranial aneurysm (IA) risk stratification. In this study, we investigated the relationship between VWE features, risk metrics, morphology and hemodynamics in 41 unruptured aneurysms. We reconstructed the IA geometries from MR angiography and mapped pituitary stalk-normalized MRI intensity on the aneurysm surface using an in-house tool. For each case, we calculated the maximum intensity (CR

Indexed as

cerebral aneurysmcomputational fluid dynamicshemodynamicsmagnetic resonance imagingvessel wall enhancement

Identifiers

PMID34804573
PMCPMC8580418
OpenAlexW3211713449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.